LSBio
TUBB2A / Tubulin Beta 2A Antibody (Acetyl-Lys379)

TUBB2A / Tubulin Beta 2A Antibody (Acetyl-Lys379)

Primary AntibodyLSBio Guarantee
Antibody:Rabbit Polyclonal
Applications:Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all Human TUBB2A / Tubulin Beta 2A antibodies →
$364.00each
Catalog Number: LS-C412264-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Tubulin Beta 2A antibody LS-C412264 is an unconjugated rabbit polyclonal antibody to Tubulin Beta 2A (TUBB2A) (Acetyl-Lys379) from human. It is reactive with human, mouse and rat. Validated for WB. Cited in 1 publication.
Application
WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
Class IIa beta-tubulin | DJ40E16.7 | TUBB2 | TUBB2A | Tubulin beta-2A chain | Tubulin, beta 2 | Tubulin, beta 2A | Tubulin, beta 2A class IIa | Beta-Tubulin | Tubulin beta-2 chain | Tubulin, beta polypeptide 2 | Tubulin, beta polypeptide
Recommended Dilution: WB
1:500 - 1:1000
UniProt Number
Q13885
SwissProt
Q13885

Target

Target
Human TUBB2A / Tubulin Beta 2A
Antigen Species
Human
Epitope
TUBB2A (Acetyl-K379) polyclonal antibody detects endogenous levels of TUBB2A protein only when acetylated at Lys379. This antibody also recognizes TUBB2B/3/4A/4B/6 protein when acetylated at the corresponding residues.
Gene Name
TUBB2A

Antibody

Host Species
Rabbit
Clonality
Polyclonal

Immunogen

Immunogen
Synthetic Acetylated peptide derived from human TUBB2A around the Acetylation site of K379.
Immunogen Type
Synthetic Peptide (Linear)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.3, 0.05% Sodium Azide
Volume
50 Microliter
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Iron control of erythroid microtubule cytoskeleton as a potential target in treatment of iron-restricted anemia. Adam N Goldfarb, Katie C Freeman, Ranjit K Sahu, Kamaleldin E Elagib, Maja Holy, Abhinav Arneja, Renata Polanowska-Grabowska, Alejandro A Gru, Zollie White rd, Shadi Khalil, Michael J Kerins, Aikseng Ooi, Norbert Leitinger, Chance John Luckey, Lorrie L Delehanty. Nature communications. 2021 March;12:1645. PubMed: 33712594 PMC: PMC7955080

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.